1-20 of 38
Jonathan H. Schatz
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Enhanced Ferroptosis Induction Susceptibility in Diffuse Large B-Cell Lymphoma through Rocaglate-Mediated Translation Inhibition

Paola Manara, Alexa Barroso, Abdessamad Youssfi Alaoui, Tyler A Cunningham, David H. Ho, Kyle Hoffman, Jonathan H. Schatz
Journal: Blood
Blood (2023) 142 (Supplement 1): 2814.
https://doi.org/10.1182/blood-2023-187443
Published: 2023
Journal Articles

Clinical Impact of Neoantigen Burden and HLA Loss in Aggressive B-Cell Lymphomas Treated with CD19 CAR T-Cell

Bachisio Ziccheddu, Michael D. Jain, Monika Chojnacka, Michael Durante, Julieta Abraham Miranda, Meghan Menges, Ola Landgren, Marco Davila, Jonathan H. Schatz, Francesco Maura, Frederick L. Locke
Journal: Blood
Blood (2023) 142 (Supplement 1): 4362.
https://doi.org/10.1182/blood-2023-182821
Published: 2023
Journal Articles

Limited Duration Loncastuximab Tesirine with Rituximab Induces High Complete Metabolic Response Rate in High-Risk Relapsed/Refractory Follicular Lymphoma - a Phase 2 Study

Juan Pablo Alderuccio, Alvaro J. Alencar, Jonathan H. Schatz, Russ Kuker, Georgio Pongas, Isildinha M. Reis, Jay Y. Spiegel, Laura Medina Andara, Lazaros J. Lekakis, Joseph S. Gyedu, Jose Sandoval-Sus, Amer M. Beitinjaneh, Nathalie Padron, Izidore S. Lossos, Joseph D. Rosenblatt, David S. Lessen, Craig H. Moskowitz
Journal: Blood
Blood (2023) 142 (Supplement 1): 984.
https://doi.org/10.1182/blood-2023-178825
Published: 2023
Journal Articles

The Marine Product Elatol Is a Novel Inhibitor of Mitochondrial Translation Triggering the Integrated Stress Response and Apoptosis in Leukemia and Lymphoma Cells

Tyler A. Cunningham, Priyanka Maiti, Paola Manara, Vivek Singh, Nigel Beaton, Alexey Amunts, Flavia Fontanesi, Antonio Barrientos, Jonathan H. Schatz
Journal: Blood
Blood (2022) 140 (Supplement 1): 7819.
https://doi.org/10.1182/blood-2022-166899
Published: 2022
Journal Articles

Translatome Reprogramming By Rocaglates in Lymphoma Induces Drug Resistance through up-Regulation of CD98hc, Activating Downstream AKT Survival Signaling

Paola Manara, Tyler A. Cunningham, J.J. David Ho, Caroline A. Coughlin, Jonathan H. Schatz
Journal: Blood
Blood (2022) 140 (Supplement 1): 8844.
https://doi.org/10.1182/blood-2022-166771
Published: 2022
Journal Articles

Poor Survival Outcomes of Checkpoint Inhibitors for B-Cell Lymphomas Relapsing after or Refractory to CAR T-Cell Therapy: A Real-World Cohort from 15 U.S. Academic Institutions

Ajay Major, Jovian Yu, Navika D. Shukla, Rachel Treitman, Manali K. Kamdar, Bradley M. Haverkos, James Godfrey, Melissa A. Babcook, Timothy J. Voorhees, Sophie G Carlson, Daria Gaut, Caspian Oliai, Jason T. Romancik, Allison Winter, Brian T. Hill, Radhika Bansal, Jose C. Villasboas, Imran A. Nizamuddin, Reem Karmali, Lindsey A. Fitzgerald, Deborah M. Stephens, Priyanka A. Pophali, Asaad Trabolsi, Jonathan H. Schatz, Marie Hu, Veronika Bachanova, Michael J Slade, Nathan Singh, Nausheen Ahmed, Joseph P. McGuirk, Michael R. Bishop, Peter A. Riedell, Justin Kline
Journal: Blood
Blood (2022) 140 (Supplement 1): 1328–1331.
https://doi.org/10.1182/blood-2022-157829
Published: 2022
Journal Articles

The Cyclin-G Associated Kinase (GAK) Is a Critical Dependency for Cell-Cycle Progression in Diffuse Large B-Cell Lymphoma Associated with Deregulation of the Retinoblastoma Tumor Suppressor

Austin D. Newsam, Preet Kumar, Olivia B. Lightfuss, Lingxiao Li, Anirban Ghoshal, Stephan Schürer, Vance Lemmon, Yangbo Feng, Hassan Al-Ali, Jonathan H. Schatz
Journal: Blood
Blood (2022) 140 (Supplement 1): 2261–2262.
https://doi.org/10.1182/blood-2022-164697
Published: 2022
Journal Articles

Whole-genome sequencing reveals complex genomic features underlying anti-CD19 CAR T-cell treatment failures in lymphoma

Michael D. Jain, Bachisio Ziccheddu, Caroline A. Coughlin, Rawan Faramand, Anthony J. Griswold, Kayla M. Reid, Meghan Menges, Yonghong Zhang, Ling Cen, Xuefeng Wang, Mohammad Hussaini, Ola Landgren, Marco L. Davila, Jonathan H. Schatz, Frederick L. Locke, Francesco Maura
Journal: Blood
Blood (2022) 140 (5): 491–503.
https://doi.org/10.1182/blood.2021015008
Published: 2022
Includes: Supplemental data
Journal Articles

A phase 2 biomarker-driven study of ruxolitinib demonstrates effectiveness of JAK/STAT targeting in T-cell lymphomas

Clinical Trials & Observations
Alison J. Moskowitz, Paola Ghione, Eric Jacobsen, Jia Ruan, Jonathan H. Schatz, Sarah Noor, Patricia Myskowski, Santosha Vardhana, Nivetha Ganesan, Helen Hancock, Theresa Davey, Leslie Perez, Sunyoung Ryu, Alayna Santarosa, Jack Dowd, Obadi Obadi, Lauren Pomerantz, Nancy Yi, Samia Sohail, Natasha Galasso, Rachel Neuman, Brielle Liotta, William Blouin, Jeeyeon Baik, Mark B. Geyer, Ariela Noy, David Straus, Priyadarshini Kumar, Ahmet Dogan, Travis Hollmann, Esther Drill, Jurgen Rademaker, Heiko Schoder, Giorgio Inghirami, David M. Weinstock, Steven M. Horwitz
Journal: Blood
Blood (2021) 138 (26): 2828–2837.
https://doi.org/10.1182/blood.2021013379
Published: 2021
Includes: Supplemental data
Journal Articles

Genomic Drivers of Large B-Cell Lymphoma Resistance to CD19 CAR-T Therapy

Michael D. Jain, Bachisio Ziccheddu, Caroline A. Coughlin, Rawan Faramand, Anthony J. Griswold, Kayla M Reid, Ola Landgren, Frederick L. Locke, Francesco Maura, Marco L. Davila, Jonathan H. Schatz
Journal: Blood
Blood (2021) 138 (Supplement 1): 42.
https://doi.org/10.1182/blood-2021-148605
Published: 2021
Journal Articles

Inhibition of Mitochondrial Translation By the Marine Natural Product Elatol Shows Potent Antileukemia Activity

Priyanka Maiti, Tyler A. Cunningham, Antonio Barrientos, Jonathan H. Schatz
Journal: Blood
Blood (2021) 138 (Supplement 1): 4342.
https://doi.org/10.1182/blood-2021-153347
Published: 2021
Journal Articles

PI3K/AKT Activation Mediates B-Cell Transformation By the "T" Splice-Variant of Fyn Kinase

Preet Kumar, Lingxiao Li, Jonathan H. Schatz
Journal: Blood
Blood (2021) 138 (Supplement 1): 4334.
https://doi.org/10.1182/blood-2021-153053
Published: 2021
Journal Articles

Is There an Unequal Benefit of Autologous Stem Cell Transplant in Different Cytogenetic Groups of High Risk Patients with Multiple Myeloma: The University of Miami Experience

Fahmin Basher, MD PhD, Sandra Sanchez, MD, Jonathan H. Schatz, MD, James E. Hoffman, MD, Lazaros J. Lekakis, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 42–43.
https://doi.org/10.1182/blood-2020-143266
Published: 2020
Journal Articles

R-Nanochop Incorporating a TFR1-Targeted Doxorubicin Nanocarrier Is Superior to R-CHOP in a PDX Model of Diffuse Large B-Cell Lymphoma

Artavazd Arumov, BSc, Piumi Y. Liyanage, PhD, Asaad Trabolsi, MD, Evan R. Roberts, BS, Braulio C. L. B. Ferreira, BS, Austin D. Newsam, BS, Daniel Bilbao, PhD, Roger M. Leblanc, PhD, Jonathan H. Schatz, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 43.
https://doi.org/10.1182/blood-2020-133482
Published: 2020
Journal Articles

Final Results of a Phase II Biomarker-Driven Study of Ruxolitinib in Relapsed and Refractory T-Cell Lymphoma

Alison J. Moskowitz, MD, Paola Ghione, MD, Eric D Jacobsen, MD, Jia Ruan, MD PhD, Jonathan H. Schatz, MD, Sarah Noor, MD, Patricia Myskowski, Helen Hancock, ANP, Theresa Davey, MMSc, PA-C, Obadi Obadi, Carlissa Onwasigwe, MPH, Nivetha Ganesan, MPH, Lauren Pomerantz, BS, Christine Jarjies, MS, Priyadarshini Kumar, Allison Sigler, Mark B. Geyer, MD, Ariela Noy, MD, David J. Straus, MD, Travis Hollmann, MD, Ahmet Dogan, MD PhD, Natasha Galasso, Giorgio Inghirami, MD, David M. Weinstock, MD, Steven M. Horwitz, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4019.
https://doi.org/10.1182/blood-2019-125017
Published: 2019
Journal Articles

Targeted Delivery of Nanocarrier-Conjugated Doxorubicin to Widen the Therapeutic Window of the Most Active Drug in Lymphoma Therapeutics

Artavazd Arumov, BSc, Piumi Y. Liyanage, BS, Asaad Trabolsi, MD, Lingxiao Li, PhD, Evan R. Roberts, BS, Daniel Bilbao, PhD, Roger M. LeBlanc, PhD, Jonathan H. Schatz, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4061.
https://doi.org/10.1182/blood-2019-122599
Published: 2019
Journal Articles

Identification of Tractable Drug-like eIF4Al Inhibitors with Potent Anti-Tumor Activity

Tyler A. Cunningham, BS, Derek Essegian, BS, MS, Stephan Schürer, PhD, Jonathan H. Schatz, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5760.
https://doi.org/10.1182/blood-2019-130494
Published: 2019
Journal Articles

NPM-ALK Upregulates Jab1/Csn5 through STAT3 Activation in Anaplastic Large Cell Lymphoma: A Novel Function of NPM-ALK That Contributes to PD1/PD-L1 Immune Checkpoint Regulation

Elias Drakos, MD PhD Prof., Konstantina Stathopoulou, MSc., Lingxiao Li, PhD, Daniel Bilbao, Vasiliki Leventaki, Pedro Farrajota Neves Da Silva, MD, Vasileios Atsaves, PhD, Anders Österborg, MD PhD, L. Jeffrey Medeiros, MD, Francisco Vega, MD PhD, Jonathan H. Schatz, MD, Francois Claret, PhD, George Z. Rassidakis, MD PhD Prof.
Journal: Blood
Blood (2019) 134 (Supplement_1): 2796.
https://doi.org/10.1182/blood-2019-130457
Published: 2019
Journal Articles

Novel Therapy for Aggressive Cutaneous T-Cell Lymphoma Leading to Complete Clinical Remission before Allogenic Stem Cell Transplantation

Nicolas Gallastegui Crestani, MD, Mohammed E. Ibrahim, CRPH, BCOP, BCPS, BCACP, Ayman M. Mohamed, PharmD, Paolo Romanelli, MD, Amer Beitinjaneh, MD MPH, MSc, Jonathan H. Schatz, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5354.
https://doi.org/10.1182/blood-2018-99-117079
Published: 2018
Journal Articles

CRISPR/Cas9 Generation of Npm1-Alk in Transplantable Murine Hematopoietic Stem Cells Accurately Models ALK-Positive Lymphoma in Recipients

Soumya Sundara Rajan, MSc, Lingxiao Li, PhD, Kranthi Kunkalla, Amit Dipak Amin, PhD, Nitin Agarwal, Francisco Vega, MD PhD, Jonathan H. Schatz, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 779.
https://doi.org/10.1182/blood-2018-99-114692
Published: 2018